🔴 Senti Biosciences is trading 5.53% down in after-hours trading — no clear catalyst identified

Senti Biosciences is trading at $0.20, down 5.53%, in after-hours trading on October 29, 2026, with the decline’s catalyst unclear.

• No clear company-specific announcement explaining the decline was identified.
• Recent coverage concerned director Edward Mathers’ resignation and the October 30 record date for contingent value rights, but did not connect either development to the move. Mixed market context also does not establish a broader-market explanation.